Tag: Neuroscience
-
Pioneering MuscleMap project secures strong philanthropic support
Posted on:
An innovative tool which could revolutionise the detection and treatment of musculoskeletal and neurological conditions will be further developed following a $230,000 gift. The donation was made following a campaign by the University of Sydney’s Advancement team and the NORTH Foundation to support the world’s first open-source dataset of whole-body muscle composition. The Kolling Institute’s
-
The Kolling hosts the brightest minds in optogenetics
Posted on:
More than 80 top national and international scientists converged on the Kolling Institute for the 4th Optogenetics Australia meeting, featuring the very latest light technologies driving research. The event attracted dynamic keynote speakers from the USA, Europe and China, and leading research institutions across Australia. Chair of Optogenetics Australia and senior Kolling Institute pain medicine
-
Researchers identify new gene linked to Meniere’s disease
Posted on:
In a crucial step towards a better understanding of Meniere’s disease, researchers at the Kolling Institute and the University of Sydney have discovered a gene mutation which could greatly inform future treatment of the disease. Meniere’s is a rare inner ear disease associated with sensorineural hearing loss, vertigo and debilitating tinnitus. There is currently no
-
roundbreaking work in geriatric pharmacology
Posted on:
For the past 20 years, Professor Sarah Hilmer has dedicated her career to optimising medicine use for older people and has achieved recognition as a national and world leader in geriatric pharmacology. Not only has the Royal North Shore Hospital clinical pharmacologist and geriatrician set about improving medication practices for older people, but she has
-
Top pain specialist and researcher receives Australia Day gong
Posted on:
Internationally respected clinical academic Professor Paul Glare has been named a Member of the Order of Australia for his significant service to medicine in the fields of pain management and palliative care. Professor Glare is a specialist physician in pain medicine and senior researcher with the Kolling Institute. He is the Director of the Michael
Category:
-
Next generation of researchers streamlining complex medication choices
Posted on:
Two emerging leaders within the Kolling Institute’s Ageing and Pharmacology Lab are gaining attention for their impressive work to improve the quality use of medications. Dr Nashwa Masnoon and Dr Kenji Fujita have received prestigious awards at the annual meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). Nashwa, who is
-
Partnership to drive innovation in genomic science
Posted on:
An exciting partnership between AGRF Ltd (Australian Genome Research Facility) and the University of Sydney and the Kolling Institute will help strengthen genomic capabilities. The partnership will see a specialised team and cutting-edge technology located within the institute to progress research in this increasingly crucial field. As Australia’s largest provider of genomic services, AGRF supports
Category:
-
Clinical trials informed by patient care
Posted on:
The Kolling Institute’s Professor Sue Kurrle and her team at the Rehabilitation and Aged Care Network at Hornsby Ku-ring-gai Hospital have been running clinical trials for 25 years, looking at dementia, frailty, and falls to name just some areas. “We do trials as it keeps you cutting edge and they are really important for our
-
New research to capture those with frailty
Posted on:
A $3-million research grant will help develop technology to identify frailty in older people in hospital, a crucial step towards improving care and long-term patient outcomes. The Kolling Institute’s Professor Sarah Hilmer will lead the large-scale study involving hospitals and universities across Australia as well as international investigators. Professor Hilmer said the five-year project will
Category:
-
Kolling Research Symposium 2024
Posted on:
We would like to thank everyone involved in the 2024 Kolling Institute Symposium. During the event, a diverse collection of researchers detailed the latest progress with their ground-breaking work into kidney and heart disease treatments, bone and muscle conditions, rare cancers, and neurological challenges. There was a focus too on the innovative work to develop